Clinical data and PASI score on the study patients.

a% change week 12 compared to week 0ball patients experienced a relapse between weeks 14–22, defined as loss of 50% of PASI improvement from baseline [5], [6].conly 1 patient experienced a rebound, said to occur if the PASI is 125% or greater than baseline, or if new generalized pustular, erythrodermic or more inflammatory psoriasis occurs within 3 months of stopping therapy [5], [6].dGenomic characterization on first 4 patients in this table.